Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02315326
Title Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge RECRUITING Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth RECRUITING Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen RECRUITING Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack RECRUITING Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Memorial Sloan Kettering Nassau RECRUITING Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field